JW Lifescience Corporation (234080.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.8x

Market Cap

KRW 173.01B

MomentumView details →

1D Return

−1.67%

YTD Return

−12.37%

RSI (14)

48.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.8x

Market Cap

KRW 173.01B

RSI (14)

48.8

MomentumView details →

1D Return

−1.67%

YTD Return

−12.37%

ProfitabilityView details →

Gross Margin

27.45%

Net Margin

10.26%

EBITDA Margin

20.42%

ROE (TTM)

11.47%

ROA (TTM)

8.51%

Asset Turnover

0.82x

GrowthView details →

Revenue YoY

+4.13%

EPS YoY

−47.40%

FCF YoY

−19.91%

Revenue CAGR 3Y

+10.92%

EPS CAGR 3Y

+24.12%

EBITDA YoY

−42.56%

EarningsView details →

EPS (Actual)

KRW 376.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

−14.95%

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

1.25x

Quick Ratio

0.81x

Div Yield

4.91%

Div Rate

KRW 550.00

Div Growth 1Y

+10.00%

Financials snapshotView financials →

Revenue (TTM)

253.71B

Net Income (TTM)

26.02B

Op. CF (TTM)

47.97B

Latest newsMore news →

No recent news for 234080.KS.

Similar companies

FutureChem Co.,Ltd220100.KQ Daewon Pharmaceutical Co., Ltd.003220.KS AptaBio Therapeutics Inc.293780.KQ BNC Korea Co., Ltd.256840.KQ REYON Pharmaceutical Co., Ltd.102460.KS Daihan Pharmaceutical Co.,Ltd.023910.KQ Find similar companies →

Latest newsMore news →

No recent news for 234080.KS.